Relapse after successful treatment with immunotherapy: lessons for the future
- PMID: 9532407
Relapse after successful treatment with immunotherapy: lessons for the future
Comment on
-
Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.Cancer J Sci Am. 1998 Mar-Apr;4(2):86-93. Cancer J Sci Am. 1998. PMID: 9532410 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical